Timothy Harkness is CFO/VP Finance at MOLECULAR DEVICES CORP (MDCC). They have made 5 open-market trades across 1 company since 2006, most recently 2014-04-29.
CIK 0001231183
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ACCL | SELL · 10b5-1 | 2013-08-27 | 2013-08-29 | $9.14 | $44K | N/A | N/A | N/A |
| ACCL | SELL · 10b5-1 | 2013-08-06 | 2013-08-07 | $9.12 | $82K | N/A | N/A | N/A |
| MDCC | SELL | 2006-02-27 | 2006-02-28 | $33.07 | $744K | N/A | N/A | N/A |
| MDCC | SELL | 2006-02-22 | 2006-02-23 | $32.65 | $898K | N/A | N/A | N/A |
| MDCC | SELL | 2006-02-21 | 2006-02-21 | $32.39 | $648K | N/A | N/A | N/A |
| MDCC | SELL | 2006-02-10 | 2006-02-14 | $28.95 | $753K | N/A | N/A | N/A |
| MDCC | SELL | 2006-02-10 | 2006-02-14 | $28.95 | $695K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.